Ellen O'Connor Vos, Director at OptimizeRx Corp (OPRX), bought 1,000 shares at $8.75 ($9K) on 2020-03-31, disclosed to the SEC on 2020-04-01.
Open-market purchase of $9k OPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| MODD | BUY | 2021-11-01 | $300K | — | Filing → |
| OPRX | BUY | 2019-11-14 | $6K | — | Filing → |
| OPRX | BUY | 2018-06-27 | $19K | — | Filing → |